Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Sussex Featured PhD Programmes
Swansea University Featured PhD Programmes
University of Reading Featured PhD Programmes

PhD in Cancer Research - Targeting neuroinflammation in mTORC1-driven brain tumours

  • Full or part time
    Dr A Tee
  • Application Deadline
    Thursday, February 28, 2019
  • Funded PhD Project (European/UK Students Only)
    Funded PhD Project (European/UK Students Only)

Project Description

This project will not only create a new brain tumour model, but will also give us valuable information on mTOR’s involvement in the development of brain tumours.
Hyperactivation of mechanistic target of rapamycin complex 1 (mTORC1) is a common occurrence in cancer, which enhances cell growth and survival. Brain tumours take advantage of mTORC1 to drive many ‘hall-marks’ of cancer. There is a clear need to generate new model systems to explore mTORC1-hyperactivation in the brain, where such models will allow us to better understand how mTORC1 impacts oncogenic processes in different brain cell lineages. To create a new and flexible mTOR-active brain model, we will knock out the Tuberous Sclerosis Complex genes, TSC1 and TSC2, by CrispR in isogenic human stem cell lines. These will be differentiated into various brain cell lineages (such as neurons, astrocytes and glial cells), and tested for mTORC1 activity, cell growth/proliferation, pro-inflammatory gene expression, and, in neurons, synaptogenesis. We will characterise the inflammatory response in these mTOR-active brain models, seeking to determine the molecular mechanisms underlying neoplastic disease. To do this, we will characterise the transcriptome of these mTORC1-active brain cells using RNA-Seq and use bioinformatic approaches to unravel mTORC1-mediated transcriptional regulation, with focus on type 1 interferon signalling, NLRP3 inflammasome and STAT3. By combining genetic analysis with computational techniques, we will determine the consequences of mTORC1 hyperactivation on brain cell behaviour. We will examine whether cytosolic mitochondrial DNA or reactive oxygen species contribute to the observed inflammatory response. Finally, we will assess drugs that target inflammatory pathway as potential treatments for mTORC1-driven brain tumours.

Funding Notes

This studentship is generously funded by Cancer Research Wales.
Full UK/EU tuition fees, Doctoral stipend matching UK Research Council National Minimum and £36,000 consumable support over the 3 years.
Open to all UK/EU students without further restrictions
A 2:1 or a 1st class in a Life Science Degree (such as Biochemistry or Biology, as examples). An additional Master’s degree or industrial experience is beneficial, but not essential.

References

CV and cover letter is required. In order to be considered you must submit a formal application via Cardiff University’s online application service. (to access the system click 'Apply Online' at the bottom of this advert)
There is a box at the top right of the page labelled ‘Apply’, please ensure you select the correct ‘Qualification’ (E.g. Doctor of Philosophy), the correct ‘Mode of Study’ (E.g. Full Time) and the correct ‘Start Date’ (E.g. October 2019). This will take you to the application portal.

Related Subjects

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2018
All rights reserved.